# GLP-1 Receptor Expression in CHI

> **NCT03768518** · — · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Congenital Hyperinsulinism

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-exendin-4 PET/CT

## Key facts

- **NCT ID:** NCT03768518
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-07
- **Primary completion:** 2019-02-01
- **Final completion:** 2019-02-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2018-12-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03768518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03768518, "GLP-1 Receptor Expression in CHI". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03768518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*